Proposed Data Collections Submitted for Public Comment and Recommendations, 71799-71800 [2012-29172]

Download as PDF 71799 Federal Register / Vol. 77, No. 233 / Tuesday, December 4, 2012 / Notices conducted over a 1-day period at each of nine acute care hospitals in one U.S. city. This pilot phase was followed in 2010 by a phase 2, limited roll-out HAI and antimicrobial use prevalence survey, conducted during July and August in 22 hospitals across 10 Emerging Infections Program sites (in California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York, Oregon, and Tennessee). Experience gained in the phase 1 and phase 2 surveys was used to conduct a full-scale, phase 3 survey in 2011, involving 183 hospitals in the 10 EIP sites. Over 11,000 patients were surveyed, and analysis of HAI and antimicrobial use data is ongoing at this time. An extension of the prevalence survey’s existing OMB approval is sought, to allow a repeat HAI and antimicrobial use prevalence survey to be performed in 2014. A repeat survey will allow further refinement of survey methodology and assessment of changes over time in prevalence, HAI distribution, and pathogen distribution. It will also allow for a re-assessment of the burden of antimicrobial use, at a time when antimicrobial stewardship is an area of active engagement in many acute care hospitals. The 2014 survey will be performed in a sample of up to 500 acute care hospitals, drawn from the acute care hospital populations in each of the 10 EIP sites (and including participation from many hospitals that participated in prior phases of the survey). Infection prevention personnel in participating hospitals and EIP site personnel will collect demographic and clinical data from the medical records of a sample of eligible patients in their hospitals on a single day in 2014, to identify CDC-defined HAIs. The surveys will provide data for CDC to make estimates of the prevalence of HAIs across this sample of U.S. hospitals as well as the distribution of infection types and causative organisms. These data can be used to work toward reducing and eliminating healthcareassociated infections—a Department of Health and Human Services (DHHS) Healthy People 2020 objective (https:// www.healthypeople.gov/2020/topics objectives2020/overview.aspx? topicid=17). This survey project also supports the CDC Winnable Battle goal of improving national surveillance for healthcare-associated infections (https:// www.cdc.gov/winnablebattles/ Goals.html). This survey assumes one respondent per hospital, a median of 75 patients per hospital, and average data collection time of 15 minutes per patient. There are no costs to respondents other than their time. The estimated annualized burden is 9,375 hours. ESTIMATED ANNUALIZED BURDEN HOURS No. of respondents Number of responses per respondent Average burden per response in hours Total burden (in hours) Respondents Form name Infection Prevention Personnel in Participating Hospitals. Data Collection Form ....................... 500 75 15/60 9,375 Total ........................................... ........................................................... ........................ ........................ ........................ 9,375 Dated: November 27, 2012. Ron Otten, Director, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2012–29173 Filed 12–3–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60 Day-13–13DB] mstockstill on DSK4VPTVN1PROD with Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and VerDate Mar<15>2010 17:31 Dec 03, 2012 Jkt 229001 instruments, call 404–639–7570 and send comments to Kimberly S. Lane, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Emerging Infections Program—New— National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 Background and Brief Description The Emerging Infections Programs (EIPs) are population-based centers of excellence established through a network of state health departments collaborating with academic institutions; local health departments; public health and clinical laboratories; infection control professionals; and healthcare providers. EIPs assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases. Various parts of the EIP have received separate Office of Management and Budget (OMB) clearances (Active Bacterial Core Surveillance [ABCs]— OMB number 0920–0802 and All Age Influenza Hospitalization Surveillance—OMB number 0920– 0852); however this request seeks to have these core EIP activities under one clearance. Activities of the EIPs fall into the following general categories: (1) Active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention/intervention projects; and (4) flexible response to public health emergencies. Activities of the E:\FR\FM\04DEN1.SGM 04DEN1 71800 Federal Register / Vol. 77, No. 233 / Tuesday, December 4, 2012 / Notices EIPs are designed to: (1) Address issues that the EIP network is particularly suited to investigate; (2) maintain sufficient flexibility for emergency response and new problems as they arise; (3) develop and evaluate public health interventions to inform public health policy and treatment guidelines; (4) incorporate training as a key function; and (5) prioritize projects that lead directly to the prevention of disease. Proposed respondents will include state health departments who may collaborate with one or more of the following: academic institutions, local health departments, public health and clinical laboratories, infection control professionals, and healthcare providers. Frequency of reporting will be determined as cases arise. The total estimated burden is 12,153 hours. There is no cost to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS * No. of respondents No. of responses per respondent Avg. burden per response (in hours) Total burden (in hours) Type of respondent Form name State Health Department .................. State Health Department .................. ABCs Case Report Form ................. Invasive Methicillin-resistant Staphylococcus aureus ABCs Case Report Form. ABCs Invasive Pneumococcal Disease in Children Case Report Form. Neonatal Infection Expanded Tracking Form. ABCs Legionellosis Case Report Form. Campylobacter ................................. Cryptosporidium ............................... Cyclospora ....................................... Listeria monocytogenes ................... Salmonella ........................................ Shiga toxin producing E. coli ........... Shigella ............................................. Vibrio ................................................ Yersinia ............................................ Hemolytic Uremic Syndrome ........... All Age Influenza Hospitalization Surveillance Project Case Report Form. 10 10 809 609 20/60 20/60 2697 2030 10 41 10/60 68 10 37 20/60 123 10 100 20/60 333 10 10 10 10 10 10 10 10 10 10 10 637 130 3 13 827 90 178 20 16 10 400 20/60 10/60 10/60 20/60 20/60 20/60 10/60 10/60 10/60 60/60 15/60 2123 217 5 43 2757 300 297 33 27 100 1000 ........................................................... ........................ ........................ ........................ 12,153 State Health Department .................. State Health Department .................. State Health Department .................. State State State State State State State State State State State Health Health Health Health Health Health Health Health Health Health Health Department Department Department Department Department Department Department Department Department Department Department .................. .................. .................. .................. .................. .................. .................. .................. .................. .................. .................. Total ........................................... Dated: November 27, 2012. Ron A. Otten, Director Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2012–29172 Filed 12–3–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60 Day-13–0017] mstockstill on DSK4VPTVN1PROD with Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To VerDate Mar<15>2010 17:31 Dec 03, 2012 Jkt 229001 request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–7570 and send comments to Ron Otten, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Application for Training (0920–0017, Expiration 03/31/2013)—Revision— PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 Scientific Education and Professional Development Program Office (SEPDPO), Office of Surveillance, Epidemiology, and Laboratory Services (OSELS), Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC offers public health training activities to professionals worldwide. Employees of hospitals, universities, medical centers, laboratories, State and Federal agencies, and State and local health departments apply for training to learn up-to-date public health practices. CDC’s training activities include laboratory training, classroom study, online training, and distance learning. CDC uses two training application forms, the Training and Continuing Education Online New Participant Registration Form and the National Laboratory Training Network Registration Form, to collect information necessary to manage and conduct training pertinent to the agency’s mission. CDC requests OMB approval to continue to collect information through E:\FR\FM\04DEN1.SGM 04DEN1

Agencies

[Federal Register Volume 77, Number 233 (Tuesday, December 4, 2012)]
[Notices]
[Pages 71799-71800]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-29172]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60 Day-13-13DB]

Proposed Data Collections Submitted for Public Comment and
Recommendations

In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570
and send comments to Kimberly S. Lane, 1600 Clifton Road, MS-D74,
Atlanta, GA 30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.

Proposed Project

Emerging Infections Program--New--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).

Background and Brief Description

The Emerging Infections Programs (EIPs) are population-based
centers of excellence established through a network of state health
departments collaborating with academic institutions; local health
departments; public health and clinical laboratories; infection control
professionals; and healthcare providers. EIPs assist in local, state,
and national efforts to prevent, control, and monitor the public health
impact of infectious diseases. Various parts of the EIP have received
separate Office of Management and Budget (OMB) clearances (Active
Bacterial Core Surveillance [ABCs]--OMB number 0920-0802 and All Age
Influenza Hospitalization Surveillance--OMB number 0920-0852); however
this request seeks to have these core EIP activities under one
clearance.
Activities of the EIPs fall into the following general categories:
(1) Active surveillance; (2) applied public health epidemiologic and
laboratory activities; (3) implementation and evaluation of pilot
prevention/intervention projects; and (4) flexible response to public
health emergencies. Activities of the

[[Page 71800]]

EIPs are designed to: (1) Address issues that the EIP network is
particularly suited to investigate; (2) maintain sufficient flexibility
for emergency response and new problems as they arise; (3) develop and
evaluate public health interventions to inform public health policy and
treatment guidelines; (4) incorporate training as a key function; and
(5) prioritize projects that lead directly to the prevention of
disease. Proposed respondents will include state health departments who
may collaborate with one or more of the following: academic
institutions, local health departments, public health and clinical
laboratories, infection control professionals, and healthcare
providers. Frequency of reporting will be determined as cases arise.
The total estimated burden is 12,153 hours. There is no cost to
respondents other than their time.

Estimated Annualized Burden Hours *
----------------------------------------------------------------------------------------------------------------
No. of Avg. burden
Type of respondent Form name No. of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
State Health Department....... ABCs Case Report 10 809 20/60 2697
Form.
State Health Department....... Invasive 10 609 20/60 2030
Methicillin-
resistant
Staphylococcus
aureus ABCs
Case Report
Form.
State Health Department....... ABCs Invasive 10 41 10/60 68
Pneumococcal
Disease in
Children Case
Report Form.
State Health Department....... Neonatal 10 37 20/60 123
Infection
Expanded
Tracking Form.
State Health Department....... ABCs 10 100 20/60 333
Legionellosis
Case Report
Form.
State Health Department....... Campylobacter... 10 637 20/60 2123
State Health Department....... Cryptosporidium. 10 130 10/60 217
State Health Department....... Cyclospora...... 10 3 10/60 5
State Health Department....... Listeria 10 13 20/60 43
monocytogenes.
State Health Department....... Salmonella...... 10 827 20/60 2757
State Health Department....... Shiga toxin 10 90 20/60 300
producing E.
coli.
State Health Department....... Shigella........ 10 178 10/60 297
State Health Department....... Vibrio.......... 10 20 10/60 33
State Health Department....... Yersinia........ 10 16 10/60 27
State Health Department....... Hemolytic Uremic 10 10 60/60 100
Syndrome.
State Health Department....... All Age 10 400 15/60 1000
Influenza
Hospitalization
Surveillance
Project Case
Report Form.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 12,153
----------------------------------------------------------------------------------------------------------------

Dated: November 27, 2012.
Ron A. Otten,
Director Office of Scientific Integrity, Office of the Associate
Director for Science, Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012-29172 Filed 12-3-12; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.